Archive for Perspectives

Introducing insitro’s TherML™: Rapidly engineering the right therapeutic for the right target

The primary driver of clinical attrition in drug discovery is often not insufficient scientific rigor, it is misalignment between the biological target and the therapeutic intervention. Discovery organizations have historically structured…

Revealing MASLD’s Genetic Architecture:
Machine Learning, Discovery, and the Path to IRS1

Last week, insitro’s work on IRS1 was recognized as a Poster of Distinction at The Liver Meeting 2025. But the real story isn’t about recognition. It’s about learning to see…

Introducing insitro’s TherML™: Rapidly engineering the right therapeutic for the right target

Revealing MASLD’s Genetic Architecture: Machine Learning, Discovery, and the Path to IRS1

Revealing MASLD’s Genetic Architecture:
Machine Learning, Discovery, and the Path to IRS1